| |
| |
|
| Insider
Information: |
Alton Gregg H |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
61,846 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,731,983 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
61,846 |
|
|
| Total
Value |
$3,731,983 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Chief Patient Officer |
2019-02-15 |
58,046 |
2018-02-20 |
0 |
Premium* |
|
|
Novavax Inc |
NVAX |
Director |
2023-06-10 |
3,800 |
2022-06-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
360 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 12 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
• • – |
2017-07-21 |
4 |
OE |
$26.99 |
$931,155 |
D/D |
34,500 |
137,488 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
• • – |
2017-08-01 |
4 |
OE |
$26.99 |
$232,789 |
D/D |
8,625 |
106,113 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
• • – |
2017-08-30 |
4 |
OE |
$24.91 |
$1,117,815 |
D/D |
43,125 |
134,238 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
• • – |
2017-09-01 |
4 |
OE |
$24.91 |
$429,611 |
D/D |
17,250 |
101,488 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
• • – |
2017-10-02 |
4 |
OE |
$24.91 |
$429,611 |
D/D |
17,250 |
93,738 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
• • – |
2017-11-01 |
4 |
OE |
$24.91 |
$214,806 |
D/D |
8,625 |
77,363 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
• • – |
2017-12-01 |
4 |
OE |
$24.91 |
$214,806 |
D/D |
8,625 |
70,988 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
• • – |
2018-01-02 |
4 |
OE |
$24.91 |
$214,806 |
D/D |
8,625 |
64,613 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
• • – |
2018-01-11 |
4 |
OE |
$24.91 |
$932,062 |
D/D |
25,875 |
75,488 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
• • – |
2018-02-01 |
4 |
OE |
$40.56 |
$699,660 |
D/D |
17,250 |
62,738 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
• • – |
2018-03-01 |
4 |
OE |
$40.56 |
$699,660 |
D/D |
17,250 |
69,426 |
0 |
- |
|
| NVAX |
Novavax Inc |
Director |
– • – |
2022-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
700 |
700 |
0 |
- |
|
| NVAX |
Novavax Inc |
Director |
– • – |
2023-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,100 |
3,800 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2005-07-27 |
4 |
S |
$45.00 |
$450,000 |
D/D |
(10,000) |
19,354 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2005-11-21 |
4 |
S |
$54.00 |
$972,799 |
D/D |
(18,010) |
19,354 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2006-07-25 |
4 |
S |
$62.00 |
$310,000 |
D/D |
(5,000) |
32,036 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2008-01-02 |
4 |
S |
$45.52 |
$898,569 |
D/D |
(19,600) |
57,517 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2008-01-02 |
4 |
S |
$45.30 |
$267,417 |
D/D |
(5,900) |
51,617 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2008-01-02 |
4 |
S |
$46.05 |
$1,408,858 |
D/D |
(30,500) |
77,117 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2008-01-04 |
4 |
S |
$47.00 |
$1,903,500 |
D/D |
(40,500) |
51,617 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2008-02-01 |
4 |
S |
$45.51 |
$275,090 |
D/D |
(6,000) |
51,617 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2008-02-29 |
4 |
S |
$47.00 |
$23,500 |
D/D |
(500) |
51,617 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2008-03-03 |
4 |
S |
$47.81 |
$313,242 |
D/D |
(6,500) |
51,617 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2008-03-25 |
4 |
S |
$50.00 |
$2,578,583 |
D/D |
(51,500) |
54,716 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2008-04-01 |
4 |
S |
$51.85 |
$366,147 |
D/D |
(7,000) |
54,716 |
0 |
- |
|
360 Records found
|
|
Page 12 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
